25 results on '"Sonke, G. S."'
Search Results
2. BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
3. P11.61.B Capecitabine treatment of CNS metastases from breast cancer: intracranial response and survival
4. Concurrent chemo-endocrine treatment for early hormone-positive breast cancer: a no-go???
5. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
6. Feasibility and outcomes of a goal-directed physical therapy program for patients with metastatic breast cancer
7. Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer
8. Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome
9. Abstract GS5-06: Towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment)
10. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
11. Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
12. Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
13. Physical problems, functional limitations, and preferences for physical therapist-guided exercise programs among Dutch patients with metastatic breast cancer: a mixed methods study
14. Enrichment of high-grade tumors in breast cancer gene expression studies
15. Patterns and predictors of first and subsequent recurrence in women with early breast cancer
16. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level
17. The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure
18. The Role of Hyperthermic Intraperitoneal Intraoperative Chemotherapy in Ovarian Cancer
19. P08.14 * SURVIVAL OF BREAST CANCER PATIENTS WITH SYNCHRONOUS OR METACHRONOUS CNS METASTASES
20. Prognostic factors for survival in metastatic breast cancer by hormone receptor status
21. Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
22. Optimising end of life care requires an individualised approach
23. Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
24. Comparison of case fatality in smokers and non-smokers after acute cardiac event
25. Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.